Skip to Content

Invesco Health Care Invstor GTHIX

Medalist Rating as of | See Invesco Investment Hub
  • NAV / 1-Day Return 41.15  /  −0.22 %
  • Total Assets 1.4 Bil
  • Adj. Expense Ratio
    1.060%
  • Expense Ratio 1.060%
  • Distribution Fee Level Average
  • Share Class Type No Load
  • Category Health
  • Investment Style Large Growth
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield
  • Turnover 59%

USD | NAV as of Jul 15, 2024 | 1-Day Return as of Jul 15, 2024, 11:32 PM GMT+0

Morningstar’s Analysis GTHIX

Will GTHIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Invesco Health Care Invstor earns a Morningstar Medalist Rating of Neutral with strength in areas such as People offset by weaker spots such as Process.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GTHIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 45.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

9.49 128.6 Mil
Healthcare

Boston Scientific Corp

5.95 80.6 Mil
Healthcare

UnitedHealth Group Inc

4.51 61.1 Mil
Healthcare

McKesson Corp

4.26 57.8 Mil
Healthcare

Merck & Co Inc

3.77 51.1 Mil
Healthcare

Danaher Corp

3.59 48.6 Mil
Healthcare

AstraZeneca PLC ADR

3.58 48.6 Mil
Healthcare

Vertex Pharmaceuticals Inc

3.58 48.6 Mil
Healthcare

Intuitive Surgical Inc

3.54 48.0 Mil
Healthcare

Thermo Fisher Scientific Inc

3.41 46.2 Mil
Healthcare